The Department of Nuclear Medicine of Jiangsu Province Hospital was founded in 1958. It was originally developed from the Division of Isotopes. After decades of effort under the leadership of Prof. Guojun Chang, Director Jingxin Zhang and Director Lihua Bao, it is now one of the import departments of Jiangsu Province Hospital with strong reputation among level III hospitals in China.
The department currently employs 40 professionals, among which 18 have senior professional titles, 4 are associate professors, 3 are master tutors.
Lihua Bao, MD
Chief Physician in Nuclear Medicine
Dr. Bao is working as Director of the Nuclear Medicine, Jiangsu Province Hospital and Director of Nuclear medicine teaching and research office of Nanjing Medical University, Nanjing, China. She is the president of osteoporosis and bone metabolism disease of Jiangsu Medical Association, the president of osteoporosis and bone metabolism disease of Nanjing Medical Association, as well as the editor of Chinese journal of osteoporosis.
Dr. Bao obtained her bachelor degree in clinical medicine from Nanjing Medical University in 1985 and published more than 30 papers in national and international academic journals as first or corresponding author and accomplished 5 books as editor. Dr. Bao received a first prize of new technology introduction award of Jiangsu provincial health department.
Dr. Bao is specialized in osteoporosis and bone metabolism disease.
Time Visits: Morning, from Monday to Tuesday.
What is Nuclear Medicine?
Nuclear medicine is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease. Nuclear medicine scans differ from radiology as the emphasis is not on imaging anatomy but the function and for such reason, it is called a physiological imaging modality. Single photon emission computed tomography (SPECT) and positron emission tomography (PET) scans are the two most common imaging modalities in nuclear medicine. Nuclear medicine imaging studies are generally more organ-, tissue- or disease-specific (e.g.: lungs scan, heart scan, bone scan, brain scan, tumor, infection, Parkinson etc.) than those in conventional radiology imaging, which focus on a particular section of the body (e.g.: chest X-ray, abdomen/pelvis CT scan, head CT scan, etc.). In addition, there are nuclear medicine studies that allow imaging of the whole body based on certain cellular receptors or functions. The radiopharmaceuticals used in nuclear medicine therapy emit ionizing radiation that travels only a short distance, thereby minimizing unwanted side effects and damage to noninvolved organs or nearby structures. Most nuclear medicine therapies can be performed as outpatient procedures since there are few side effects from the treatment and the radiation exposure to the general public can be kept within a safe limit.
Metabolic bone diseases.
Differentiated thyroid carcinoma.
Other thyroid and parathyroid problems.
Malignant tumor: diagnosis, stage, re-stage, outcome evaluation, assess treatment, etc.
Cerebral vascular diseases.
Bony scan: bone tumor.
Parathyroid imaging: hyperparathyroidism.
Thyroid imaging: thyroid diseases.
Renal imaging: GFR and ERPF.
Lung perfusion and ventilation imaging: (PE).
Myocardial perfusion imaging: CAD
Myocardial metabolic imaging: viable myocardium evaluation.
Myocardial blood pool imaging: heart function.
4.RAIU: thyroid diseases.
5.Immunoassay in vitro.
Production of positron compounds.
Since 2008, our department began to send out the excellent staff abroad. 10 persons had the experienced to learn abroad with the Scholar and participate the international meeting.